Pancreatic neuroendocrine neoplasms (pNENs) are a group of clinically rare and heterogeneous diseases of the pancreas. However, the prognostic factors for this disease in patients still remain controversial. The purpose of our study is to evaluate the predictive roles of those prognostic factors for pNENs. All related articles published until Sep 17, 2017 were identified via PubMed, EMBASE, Web of Science, Ovid and the Cochrane Library. Studies that examined the prognostic factors of pNENs were enrolled. 17 articles (2822 patients) were finally included in this study. The pooled data suggested that patients with positive surgical resection margin and lymph node, advanced G stage and TMN stage, organ metastasis, vascular invasion and the necrosis of specimens had a decreased overall survival for pNENs. Similarly, patients with functional tumors might have a poor prognosis. However, age, gender, surgical type and size of tumor could not be regarded as prognostic factors for pNENs. Our analytic data demonstrated that surgical resection margin, G stage, TMN stage, lymph node, metastasis, vascular invasion and the necrosis could be prognostic factors for pNENs. Our study may assist doctors to screen patients with different prognosis more efficiently during follow-up and select appropriate treatment measures.
included were published from 2007 to 2017. Study period ranged from 1964 to 2015. Among them, 11 studies studied the patients from Asian countries, including Japan (2), South Korea (1), and China (8); 7 studies investigated the patients from European countries and North American countries, including America (3), Germany (2), Spain (1) and Norway (1) . All of studies were retrospective studies. Moreover, the results of study quality assessment were also listed in Table 1 .
Prognostic factors for pancreatic neuroendocrine neoplasms. clinical feature prognostic factors. 3
clinical feature prognostic factors were analyzed in this study, including gender, age, and function. All pooled data about these factors were shown in Table 2 .
Gender. A total of 4 articles 13, 17, 18, 21 assessed the effect of gender on the prognosis of pNENs. 3 of them 13, 17, 18 considered that there was no difference in prognosis between male and female patients and the pooled hazard ratio (HR) and 95% confidence interval (CI) supported this view. The rest one 21 showed that male patients might have a poor prognosis of pNENs (Table 2 , Fig. 2A ). According to the subgroup analysis, equal survival tendency to males and females was only observed in results obtained from studies with larger sample size, and performed in Asia area.
Age. 1 of 4 articles
13 suggested that patients with older age had a worse outcome than the patient with younger age (Table 2 , Fig. 2B ). However, the combined data and all subgroup results all showed that there was no significant difference between young patients and old patients. Function. Function was enrolled in 7 articles 11, 13, 14, 16, 18, 22, 27 . Although up to 5 of 7 articles 11, 13, 18, 22, 27 found no statistically significant difference in the prognosis of functional and nonfunctional tumors, the combined result reported that functional tumors could improve the prognosis of pNENs (Table 2, Fig. 2C ), as well as the subgroup results based on the articles enrolled more than or equal to 80 patients or published in western countries. However, articles published in Asia agreed with the previous point. Surgery related prognostic factors. 2 surgery related prognostic factors were investigated in our study. All synthetic data about these factors were shown in Table 3 .
Surgical margin. 1 of 4 article 12 showed that there was no significant difference between patients with positive and negative surgical resection margin (Table 3 , Fig. 2D ). However, the combined result and subgroup result based on articles more than 80 patients all revealed that negative surgical margin was another positive prognostic factor for pNENs.
Surgical type. Nils D. Arvold et al. 17 suggested that more extensive surgery was associated with decreased OS but the study 23 carried by Marcus Bahra et al. showed inconsistent trend (Table 3 , Fig. 2E ).
Pathology related prognostic factor. 7 pathology related prognostic factors were assessed in our study. All combined data about these factors were shown in the Table 4 .
G stage. 2 of 6 studies 13, 21 suggested that poor prognosis of pNENs was associated with advanced G stage, while 4 of 6 studies 12, 20, 26, 27 had no statistical difference between people with high or low G stage. Our pooled data showed that patients with advanced G stage were prone to suffer from pNENs (Table 4 , Fig. 3A) . Meanwhile, subgroup analysis suggested that G stage is a negative prognostic factor for pNENs according to the pooled data from articles published in Asian and articles with more than or equal to 80 patients TMN stage. TMN stage was mentioned in 4 articles 18, 22, 24, 25 . On the basis of current knowledge, people with advanced TMN stage are more likely to have a negative outcome. However, only 1 article 18 , along with combined data and subgroup analysis approved this standpoint. The rest articles showed no difference.
Lymph node. While 2 of 6 articles 19, 23 showed no difference in people with or without lymph node invasion, 4 articles 17, [20] [21] [22] reflected that people with lymph node invasion had worse prognosis than people without lymph node invasion. The combined data subordinate to the majority (Table 4 , Fig. 3B ). In the subgroup analysis, poor prognosis was associated with the people with lymph node invasion based on the articles with large samples and studies conducted in Asian or western countries.
Vascular invasion. 2 articles
13,25 with more than 80 patients supported that vascular invasion involvement is related to a poor outcome. In contrast, 1 article 22 with small samples suggested that there is no difference in people with or without vascular invasion (Table 4 , Fig. 3C ).
Organ Metastasis. Present organ metastasis might indicate low overall survival of pNENs according to the data provided by 3 of 4 articles 13, 20, 27 and the combined data (Table 4 , Fig. 3D ). All subgroup analysis also showed the identical results.
Tumor size. 5 studies 17, 19, 21, 24, 26 were mentioned in our study. 4 19, 21, 24, 26 of them showed no correlation with the size of tumor and prognosis of pNENs.1 of them suggested that people with tumor in large size might have a poor prognosis. 
Necrosis

Discussion
Pancreatic neuroendocrine tumors are rare and heterogeneous tumors with poorly defined natural history and uncertain biological behavior 28, 29 . With advances in imaging techniques, pNETs are now being detected with increasing frequency in many regions of the world 30 . However, there is still no set of standard rules to determine the prognosis of patients. In this study, we reviewed several related prognostic factors for pNENs to further confirm their roles.
As far as we know, we, for the first time, assessed the significance of prognostic factors above for pNENs in a meta-analysis. Based on the combined HR and 95% CI, we believe that negative prognostic factors consists of positive surgical resection margin and lymph node, advanced G stage and TMN stage, present organ metastasis, vascular invasion and the necrosis of specimens. Thus, patients with aforementioned factors should gain more attention and be examined more frequently during the follow-up. However, the only one positive prognostic factor is function. Therefore, patients with non-functional tumors should also show more concern on themselves.
Furthermore, our study found that many other prognostic factors such as age, gender, surgical type and size of tumor do not play a decisive role in the process of pNENs. We might have a conservative view for these factors due to the lack of enrolled studies and the limited sample size. Therefore, more studies about some potential prognostic factors were greatly needed, especially studies with a large number of patients. To reduce the effect of small samples and regional disparity on heterogeneity, we performed the subgroup analysis based on sample size and nationality of patients. For almost all of subgroup analysis, we found that there is a small change in the value of combined 95% CI based on the large samples and patients in Asia or western countries, but the relationship between 95% CI and 1 hasn't changed. Therefore, there is no decisive effect on heterogeneity in the studies based on small sample and geographic distance. For function, the nationality of patients was identified as main factor resulting in heterogeneity. Of course, many other factors could also result in the heterogeneity, such as year of articles.
There are some limitations concerning this study. Firstly, some articles only provide Kaplan-Meier curve but not HR or follow-up data. During the process of computation, we may increase the deviation from the original data. In addition, many other factors might be responsible for the overall survival. However, due to the lack of sufficient articles or effective data, they were not assessed in our study. Moreover, the cutoff value to define high and low or positive and negative varies among some studies, which increased the difficulty with performing a pooled study. Last but not least, randomized controlled trials were in need to improve the reliability of reported data.
In conclusion, this meta-analysis indicates that positive surgical resection margin and lymph node, advance G stage and TMN stage, present organ metastasis, vascular invasion and the necrosis of specimens might be associated with a poor prognosis of pNENs.
These findings will provide important theoretical basis for improvement in clinical follow-up of patients with pNENs and may increase overall survival in a long term. However, due to the limitations mentioned above, further well-designed studies with larger sample size are required to confirm the predictive roles of those factors. 
Materials and Methods
Inclusion and exclusion criteria.
Studies were included if they met the following criteria:
(a) pancreatic neuroendocrine tumor was histopathologically diagnosed. (b) Relevant risk estimated in terms of hazard ratio with 95% confidence interval, or KM curve was provided.
The following criteria were applied to exclude studies: Study quality assessment. The quality of included studies was assessed by two independent reviewers according to the Newcastle-Ottawa Quality Assessment Scale for cohort studies (NOS) recommended in the Cochrane Handbook version 5.1.0 31 . NOS is comprised of three parameters (eight elements, nine stars total) for quality: selection (four elements, one star each), comparability (one element, up to two stars) and outcome (three elements, one star each). The high-quality choices for each element are marked with a star, and then the number of stars is counted to evaluate the quality of each study. Studies are regarded as high quality if they are awarded six stars or more 32 . Data extraction. Two independent researchers carefully reviewed each eligible article and extracted the data. Any controversial data were resolved by a third researcher. For each enrolled study, the basic information extracted was shown: author name, year of publication, country, study types, study period and sample size. Potential prognostic factors mentioned in more than or equal to two articles were recorded. Gender, age, function, surgical type and margin, G and TMN stage, lymph node and vascular invasion, organ metastasis, tumor size and necrosis were finally selected. Subsequently, the number of articles, Hazard ratio, 95% confidence interval (CI) were acquired for each prognostic factor. If the data could not be obtained directly, we extracted survival rates from Kaplan-Meier survival curve, imported the data into Engauge Digitizer 4.1 to and calculated relative values with the method mentioned in article published by Jayne F Tierney et al. 33 .
Statistical analysis. Review Manager software (version 5.3; Cochrane Collaboration, Oxford, United Kingdom) was applied to perform this meta-analysis and provide related graphics. Combined hazard ratio is presented as forest plots. Subgroup analysis was performed stratifying on the sample size (>80 vs. <80) and study area(Asian area vs. Western area). Cochran's Q test and Higgins' I-squared test were used to test heterogeneity between studies. Heterogeneity would not be considered significant if the P -value for Cochran's Q test was greater than or equal to 0.1. In the absence of statistically significant heterogeneity, a fixed effects model was used to combine the data. Otherwise, a random effects model was applied.
